The emerging therapy of the medication represents a exciting breakthrough in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide impacts dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide167242.link4blogs.com/62862881/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment